Cl. Meschter et al., A 13-WEEK TOXICOLOGIC AND PATHOLOGICAL EVALUATION OF PROLONGED CYTOCHROMES P450 INHIBITION BY 1-AMINOBENZOTRIAZOLE IN MALE-RATS, Fundamental and applied toxicology, 22(3), 1994, pp. 369-381
The pharmacologic, toxicologic, and microscopic effects of 100 mg/kg/d
ay of 1-Aminobenzotriazole (ABT), a suicide substrate inhibitor of cyt
ochromes P450, were assessed in male Sprague-Dawley rats over a 13-wee
k period. Hepatic cytochromes P450 levels and resorufin dealkylase act
ivity were decreased to less than 30% of control values beginning at D
ay 2 and from Day 8 to Day 92. These decreases were not accompanied by
overt clinical toxicity, e.g., changes in body weight, food consumpti
on, or clinical appearance, during the study. Hemoglobin, hematocrit,
and erythrocyte counts were slightly decreased at 8, 29, and 92 days a
nd were accompanied by increased spleen weights and extramedullary hem
atopoiesis. Additionally, mean corpuscular hemoglobin concentration, m
ean corpuscular volume, red cell distribution width, and mean corpuscu
lar hemoglobin were slightly increased at 92 days. Increases in liver
weights at 8, 29, and 92 days were accompanied by centrilobular hypert
rophy and intracytoplasmic vacuolization consistant with lipid accumul
ation. Thyroid stimulating hormone (TSH) was slightly elevated and tri
iodothyronine and thyroxine were slightly decreased at 29 days. TSH wa
s also slightly elevated at 8 and 92 days, and thyroid gland weights w
ere increased at 8, 29, and 92 days with microscopic evidence of hyper
plasia and hypertrophy of thyroid gland follicular cells. Increased ad
renal weights and hypertrophy of the zona fascicularis of the adrenal
gland were observed at 8, 29, and 92 days. Kidney weights were also in
creased at these assessments. Changes in the thyroid gland, the thyroi
d hormone profile, and the liver may reflect increased synthesis of mi
crosomal enzymes, an effect that is sometimes difficult to demonstrate
directly with suicide substrate inhibitors of cytochromes P450. In ge
neral, the effects of daily ABT administration to male rats at a dose
that significantly reduces oxidative metabolism over a 13-week period
were considered to be well-tolerated under controlled laboratory condi
tions. (C) 1994 Society of Toxicology.